Epicardial fat thickness and cardio-ankle vascular index without other inflammatory markers may not provide information to clinicians about the systemic inflammation

Cardiology (Switzerland)

Volumn 125, Issue 1, 2013, Pages 13-14

  Balta, Sevket ^a   Demirkol, Sait ^a   Kucuk, Ugur ^a   Unlu, Murat ^a   Dinc, Mustafa ^b   Arslan, Zekeriya ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Beytepe Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FAT;

ANGIOCARDIOGRAPHY; ARTERIAL STIFFNESS; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DEVELOPED COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENDOTHELIAL DYSFUNCTION; EPICARDIAL FAT THICKNESS; EPICARDIUM; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; LETTER; MEDICAL INFORMATION; MORTALITY; NON INVASIVE PROCEDURE; PHYSICIAN; PRIORITY JOURNAL;

EID: 84876456189     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000348339     Document Type: Letter

References (10)

1. Gökdeniz T, Turan T, Aykan AÇ, Gül I, Boyaci F, Hatem E, Bektas H, Celik S: Relation of epicardial fat thickness and cardio-ankle vascular index to complexity of coronary artery disease in nondiabetic patients. Cardiology 2013; 124: 41-48.
2. Pagley PR, Goldberg RJ: Coronary artery disease in women: a population-based perspective. Cardiology 1995; 86: 265-269.
3. Lai Y-H, Yun C-H, Yang F-S, Liu C-C, Wu Y-J, Kuo J-Y, et al: Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography. J Am Soc Echocardiogr 2012; 25: 234-241.
4. Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, et al: Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 2013; 226: 129-133.
5. Altun B, Bulucu F, Demirbas S, Karaman M, Ay SA, Cakar M, et al: The relationship between some of the cardiovascular risk factors and arterial stiffness parameters in essentially hypertensive patients. Clin Exp Hypertens 2012, E-pub ahead of print.
6. Sukhija R, Aronow WS, Yalamanchili K, Peterson SJ, Frishman WH, Babu S: Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease. Cardiology 2005; 103: 158-160.
7. Demirkol S, Balta S, Unlu M, Yuksel UC, Celik T, Arslan Z, et al: Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics 2012; 67: 1019-1022.
8. Karaman M, Balta S, Ay SA, Cakar M, Naharci I, Demirkol S, et al: The comparative Effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens 2013, E-pub ahead of print.
9. Herzog CA: Kidney disease in cardiology. Nephrol Dial Transplant 2009; 24: 34-37.
10. Demirkol S, Balta S, Unlu M, Arslan Z, Cakar M, Kucuk U, et al: Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost 2012, E-pub ahead of print.